Author Correction: SREBP1 drives keratin-80- dependent cytoskeletal changes and invasive
behavior in endocrine-resistant ER α breast cancer
Ylenia Perone 1,14 , Aaron J. Farrugia 2,14 , Alba Rodríguez-Meira 1,12,14 , Balázs Gy ő rffy 3,4 , Charlotte Ion 1 , Andrea Uggetti 5 , Antonios Chronopoulos 6 , Pasquale Marrazzo 7 , Monica Faronato 8 , Sami Shousha 9 , Claire Davies 10 , Jennifer H. Steel 10 , Naina Patel 10 , Armando del Rio Hernandez 6 , Charles Coombes 1 , Giancarlo Pruneri 11 , Adrian Lim 1 , Fernando Calvo 2,13 & Luca Magnani 1
Correction to: Nature Communications https://doi.org/10.1038/s41467-019-09676-y, published online 9 May 2019.
This Article contained an error in the name of the author Alba Rodríguez-Meira, which was incorrectly given as Alba Rodríguez Meira.
These errors have been corrected in the PDF and HTML versions of the article.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visithttp://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2019
https://doi.org/10.1038/s41467-019-11801-w
OPEN
1Department of Surgery and Cancer, Imperial College London, London, UK.2Division of Cancer Biology, Tumour Microenvironment Team, Institute of Cancer Research, London, UK.3MTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Hungarian Academy of Sciences, Budapest, Hungary.
42nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.5European Institute of Oncology, Milan, Italy.6Faculty of Engineering, Department of Bioengineering, Imperial College London, London, UK.7Department for Life Quality Studies, Alma Mater Studiorum, University of Bologna, Rimini, Italy.8Department of Chemistry, Imperial College London, London, UK.9Histopathology Department, Imperial College London, Charing Cross Hospital NHS Trust, London, UK.10ECMC Imperial College. Department of Surgery and Cancer, Imperial College London, London, UK.11Pathology Department, Fondazione IRCCS Istituto Nazionale Tumori and University of Milan, School of Medicine, Milan, Italy.12Present address: MRC Molecular Haematology Unit, Haematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.13Present address: Instituto de Biomedicina y Biotecnologia de Cantabria, Santander, Spain.14These authors contributed equally: Ylenia Perone, Aaron J. Farrugia, Alba Rodriguez-Meira.
Correspondence and requests for materials should be addressed to F.C. (email:calvof@unican.es) or to L.M. (email:l.magnani@imperial.ac.uk)
NATURE COMMUNICATIONS| (2019) 10:3791 | https://doi.org/10.1038/s41467-019-11801-w | www.nature.com/naturecommunications 1
1234567890():,;
